Coval Biopharma Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Investors
  • 2

Coval Biopharma General Information

Description

Developer of special preparations designed for medical health. The company has developed a molecular coupling technology platform, and it combines with local drug delivery dosage forms (intracavitary/subcutaneous injection, topical application, inhalation, etc.), providing customers with innovative topical drugs to address currently unmet clinical needs.

Contact Information

Website
www.coval-biopharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, No. 22, Lane 908, Ziping Road
  • Pudong New District
  • Shanghai, 201318
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 2nd Floor, No. 22, Lane 908, Ziping Road
  • Pudong New District
  • Shanghai, 201318
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Coval Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 15-Mar-2022 Announced Pre-Clinical Trials
3. Later Stage VC 27-Aug-2024 Completed Pre-Clinical Trials
2. Early Stage VC 15-Mar-2022 $16.2M $16.2M Completed Pre-Clinical Trials
1. Seed Round 08-Oct-2019 Completed Startup
To view Coval Biopharma’s complete valuation and funding history, request access »

Coval Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Coval Biopharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Time Asset Management (Shanghai) Growth/Expansion Minority
TF Capital Venture Capital Minority
To view Coval Biopharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Coval Biopharma FAQs

  • When was Coval Biopharma founded?

    Coval Biopharma was founded in 2019.

  • Where is Coval Biopharma headquartered?

    Coval Biopharma is headquartered in Shanghai, China.

  • What is the size of Coval Biopharma?

    Coval Biopharma has 9 total employees.

  • What industry is Coval Biopharma in?

    Coval Biopharma’s primary industry is Drug Discovery.

  • Is Coval Biopharma a private or public company?

    Coval Biopharma is a Private company.

  • What is Coval Biopharma’s current revenue?

    The current revenue for Coval Biopharma is .

  • How much funding has Coval Biopharma raised over time?

    Coval Biopharma has raised $16.2M.

  • Who are Coval Biopharma’s investors?

    Time Asset Management (Shanghai) and TF Capital have invested in Coval Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process